Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Fukuhara · SciRah

Researcher profile · Semantic Scholar

N. Fukuhara

Share profile

N. Fukuhara — researcher profile on SciRah

h-index: 24
Works: 213
Citations: 2,803

Most-cited papers

Phase I/II study of tirabrutinib, a second-generation Bruton’s tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma
Y. Narita, M. Nagane, K. Mishima, Y. Terui +9 more
2020Neuro-Oncology158 citations Open access
Semantic Scholar
Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification.
Ichiro Yonese, C. Sakashita, K. Imadome, Tohru Kobayashi +15 more
2020Blood Advances85 citations Open access
Semantic Scholar
A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström’s macroglobulinemia
N. Sekiguchi, S. Rai, W. Munakata, Kenshi Suzuki +11 more
2020Cancer Science76 citations Open access
Semantic Scholar
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
K. Shimada, M. Yamaguchi, Y. Atsuta, K. Matsue +30 more
2020The Lancet Oncology74 citations
Semantic Scholar
A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma
Y. Terui, S. Rai, K. Izutsu, M. Yamaguchi +17 more
2021Cancer Science49 citations Open access
Semantic Scholar
Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma
Hidetsugu Kawai, K. Ando, D. Maruyama, Kazuhito Yamamoto +17 more
2021Cancer Science47 citations Open access
Semantic Scholar
Two‐year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia
N. Sekiguchi, S. Rai, W. Munakata, Kenshi Suzuki +11 more
2022Cancer Science32 citations Open access
Semantic Scholar
A phase 3 randomized study (HOMER) of ofatumumab vs rituximab in iNHL relapsed after rituximab-containing therapy.
D. Maloney, M. Ogura, N. Fukuhara, Jaclyn Davis +4 more
2020Blood Advances27 citations Open access
Semantic Scholar
Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B‐cell lymphoma
K. Izutsu, T. Kumode, J. Yuda, H. Nagai +16 more
2023Cancer Science26 citations Open access
Semantic Scholar
Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan
H. Goto, T. Kitawaki, N. Fujii, K. Kato +13 more
2023International Journal of Clinical Oncology23 citations
Semantic Scholar
Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome
T. Ochi, Tohru Fujiwara, K. Ono, Chie Suzuki +10 more
2022Scientific Reports23 citations Open access
Semantic Scholar
Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis
K. Ono, Tohru Fujiwara, Kei Saito, Hironari Nishizawa +14 more
2022Scientific Reports23 citations Open access
Semantic Scholar
A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial.
K. Ohmachi, T. Kinoshita, K. Tobinai, G. Ogawa +29 more
2021Blood Advances22 citations Open access
Semantic Scholar
Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study
N. Fukuhara, G. Yamamoto, H. Tsujimura, T. Chou +4 more
2019Leukemia and Lymphoma22 citations
Semantic Scholar
Oral Azacytidine in Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: Final Analysis of the Oracle Phase III Study
J. Dupuis, K. Tsukasaki, E. Bachy, F. Morschhauser +18 more
2022Blood19 citations Open access
Semantic Scholar
Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma
K. Izutsu, Kazuhito Yamamoto, Koji Kato, T. Ishikawa +10 more
2020International journal of hematology17 citations
Semantic Scholar
Elucidation of the Role of FAM210B in Mitochondrial Metabolism and Erythropoiesis
Chie Suzuki, Tohru Fujiwara, Hiroki Shima, K. Ono +10 more
2022Molecular and Cellular Biology15 citations Open access
Semantic Scholar
Final results of a phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma
D. Maruyama, Y. Terui, Kazuhito Yamamoto, N. Fukuhara +5 more
2020Japanese Journal of Clinical Oncology14 citations Open access
Semantic Scholar
Hepatic niche leads to aggressive natural killer cell leukemia proliferation through transferrin-transferrin receptor 1 axis.
Kazuaki Kameda, Ryo Yanagiya, Yuji Miyatake, J. Carreras +25 more
2023Blood13 citations
Semantic Scholar
High-throughput liquid chromatography/electrospray ionization tandem mass spectrometry method using in-source collision-induced dissociation for simultaneous quantification of imatinib, dasatinib, bosutinib, nilotinib, and ibrutinib in human plasma.
Tensei Hirasawa, M. Kikuchi, Kensuke Shigeta, Shinya Takasaki +8 more
2021Biomedical chromotography11 citations
Semantic Scholar
Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study
W. Kim, N. Fukuhara, D. Yoon, Kazuhito Yamamoto +15 more
2023Blood Advances10 citations Open access
Semantic Scholar
Venetoclax in combination with azacitidine in Japanese patients with acute myeloid leukaemia: phase 1 trial findings.
S. Taniguchi, T. Yamauchi, I. Choi, N. Fukuhara +7 more
2021Japanese Journal of Clinical Oncology10 citations
Semantic Scholar
Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
Kazuhito Yamamoto, A. Shinagawa, C. Dinardo, K. Pratz +19 more
2021Japanese Journal of Clinical Oncology10 citations Open access
Semantic Scholar
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105)
D. Maruyama, S. Iida, G. Ogawa, N. Fukuhara +21 more
2020British Journal of Haematology10 citations Open access
Semantic Scholar
Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome
S. Terakura, Tetsuya Nishida, M. Sawa, Tomonori Kato +27 more
2020Bone Marrow Transplantation10 citations Open access
Semantic Scholar
Successful treatment of methotrexate-associated classical Hodgkin lymphoma with brentuximab vedotin-combined chemotherapy: a case series
S. Ichikawa, N. Fukuhara, Kei Saito, Koichi Onodera +6 more
2020International journal of hematology10 citations
Semantic Scholar
Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data
S. Matsuda, R. Suzuki, Tsutomu Takahashi, Y. Suehiro +10 more
2020International journal of hematology9 citations
Semantic Scholar
Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignancies
W. Munakata, K. Ando, M. Yokoyama, N. Fukuhara +9 more
2022International journal of hematology8 citations Open access
Semantic Scholar
Parsaclisib in Japanese patients with relapsed or refractory B‐cell lymphoma (CITADEL‐111): A phase Ib study
N. Fukuhara, Y. Suehiro, Harumi Kato, S. Kusumoto +6 more
2022Cancer Science8 citations Open access
Semantic Scholar
Successful Treatment of Life-threatening Bleeding Caused by Acquired Factor X Deficiency Associated with Respiratory Infection
S. Ichikawa, Kei Saito, N. Fukuhara, Yu Tanaka +6 more
2020Internal medicine8 citations Open access
Semantic Scholar
Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial
N. Fukuhara, Koji Kato, H. Goto, Takeshi Tajima +9 more
2022International journal of hematology7 citations Open access
Semantic Scholar
Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL
K. Miyazaki, R. Sakai, Noriko Iwaki, G. Yamamoto +31 more
2023Cancer Science6 citations Open access
Semantic Scholar
A first-in-human phase I study of CTX-712 in patients with advanced, relapsed or refractory malignant tumors.
Toshio Shimizu, K. Yonemori, T. Koyama, Katsuya Yuki +13 more
2022Journal of Clinical Oncology6 citations
Semantic Scholar
Diffuse Large B-cell Lymphoma Presenting as Peritoneal Lymphomatosis: A Case Report and Literature Review
S. Ichikawa, N. Fukuhara, Kei Saito, Koichi Onodera +4 more
2021Internal medicine6 citations Open access
Semantic Scholar
Disseminated gonococcal infection in a patient with paroxysmal nocturnal haemoglobinuria receiving eculizumab.
Ikumi Niitsuma-Sugaya, H. Kanamori, S. Ichikawa, N. Fukuhara +7 more
2021Lancet. Infectious Diseases (Print)6 citations
Semantic Scholar
Primary adrenal extranodal NK/T-cell lymphoma: A case report and literature review
S. Ichikawa, Kei Saito, N. Fukuhara, Hisayuki Yokoyama +4 more
2020Leukemia Research Reports6 citations Open access
Semantic Scholar
Long‐term outcomes and central nervous system relapse in extranodal natural killer/T‐cell lymphoma
K. Miyazaki, R. Suzuki, M. Oguchi, S. Taguchi +27 more
2022Hematological Oncology5 citations
Semantic Scholar
TM5614, an Inhibitor of Plasminogen Activator Inhibitor-1, Exerts an Antitumor Effect on Chronic Myeloid Leukemia.
Katsuyuki Sasaki, Tohru Fujiwara, T. Ochi, K. Ono +8 more
2022Tohoku journal of experimental medicine5 citations Open access
Semantic Scholar
A First-in-Human Phase I Study of CTX-712 in Patients with Advanced, Relapsed or Refractory Malignant Tumors - Hematologic Malignancies Dose Escalation Cohort
Hisayuki Yokoyama, K. Ando, N. Fukuhara, H. Iida +10 more
2022Blood5 citations
Semantic Scholar
Phase 1b study to investigate the safety and tolerability of idelalisib in Japanese patients with relapsed/refractory follicular lymphoma and chronic lymphocytic leukemia.
N. Fukuhara, T. Kinoshita, Kazuhito Yamamoto, H. Nagai +9 more
2020Japanese Journal of Clinical Oncology5 citations
Semantic Scholar
Long-term survival after cord blood transplantation for acute myeloid leukemia complicated with disseminated fusariosis.
S. Ichikawa, N. Fukuhara, S. Watanabe, Yoko Okitsu +3 more
2020Journal of Infection and Chemotherapy5 citations
Semantic Scholar
Final three-year follow-up analysis of phase I/II study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma.
Katsunori Asai, Y. Narita, M. Nagane, K. Mishima +8 more
2023Journal of Clinical Oncology4 citations
Semantic Scholar
Long-term endoscopic remission in Crohn’s disease after allogeneic hematopoietic stem cell transplantation for diffuse large B cell lymphoma: case report and literature review
Y. Inomata, Masatake Kuroha, Tomoyuki Handa, Yusuke Shimoyama +8 more
2021Clinical Journal of Gastroenterology4 citations
Semantic Scholar
A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin
Tetsuya Nishida, Takeshi Kobayashi, M. Sawa, Shinichi Masuda +22 more
2021Annals of Hematology4 citations Open access
Semantic Scholar
Extranasal extranodal NK/T-cell lymphoma associated with systemic lupus erythematosus
S. Ichikawa, N. Fukuhara, T. Shirai, T. Ishii +2 more
2020International journal of hematology4 citations
Semantic Scholar
Ibrutinib in Japanese patients with relapsed/refractory B-cell malignancies: final analysis of phase I study
K. Tobinai, T. Uchida, N. Fukuhara, T. Nishikawa
2019International journal of hematology4 citations
Semantic Scholar
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study
N. Fukuhara, D. Maruyama, K. Hatake, H. Nagai +17 more
2022International journal of hematology3 citations Open access
Semantic Scholar
Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105)
D. Maruyama, S. Iida, R. Machida, S. Kusumoto +24 more
2022Cancer Science3 citations Open access
Semantic Scholar
Anaplastic multiple myeloma with MYC rearrangement
S. Ichikawa, N. Fukuhara, Kokichi Hashimoto, F. Fujishima +2 more
2021Leukemia Research Reports3 citations Open access
Semantic Scholar
Salvage Cord Blood Transplantation for Sustained Remission of Acute Megakaryoblastic Leukemia That Relapsed Early after Myeloablative Transplantation
S. Ichikawa, Tohru Fujiwara, Kei Saito, Kazuki Sakurai +7 more
2021Internal medicine3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Ichikawa×15
Invite
S. Ichikawa — researcher profile on SciRah
H. Harigae×15
Invite
H. Harigae — researcher profile on SciRah
Yasushi Onishi×14
Invite
Yasushi Onishi — researcher profile on SciRah
Koichi Onodera×12
Invite
Koichi Onodera — researcher profile on SciRah

Hisayuki Yokoyama

×12

Invite

Hisayuki Yokoyama — researcher profile on SciRah

Invite

K. Izutsu — researcher profile on SciRah

Invite

Y. Terui — researcher profile on SciRah

Invite

Y. Suehiro — researcher profile on SciRah

Kazuhito Yamamoto×10

Invite

Kazuhito Yamamoto — researcher profile on SciRah

Invite

K. Tobinai — researcher profile on SciRah

Invite

H. Nagai — researcher profile on SciRah

Invite

D. Maruyama — researcher profile on SciRah